Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.
Clinical trial NCT02740335 · COMPLETED
Trial details
- NCT number
- NCT02740335
- Sponsor
- Octapharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-08
- Primary completion
- 2022-02-23
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.